Do non-targeted gastric biopsies affect the management of patients, and can a simple protocol and education reduce the rate?

Objective

To determine whether development of localised protocol could reduce the number of non-targeted gastric biopsies taken at endoscopy, without risking harm from non-detection of malignant conditions.

Design

Retrospective analysis of patient records over a 3-month period in 2013, repeated in 2015 following intervention.

Setting

Two UK teaching hospitals

Patients

Patient record data on indication for endoscopy, endoscopy findings, histopathology results and patient outcome.

Interventions

Guidance on upper gastrointestinal biopsy in the form of a new trust-wide protocol, as well as lecture-based education.

Main outcome measures

Rates of non-targeted and targeted biopsies before and after intervention, and differences between grade of endoscopist.

Results

Between 2013 and 2015, there was a 36% reduction in non-targeted biopsies (10.4% vs 6.7%, p=0.001), predominantly within registrar and nurse endoscopist groups, with reduction in non-targeted biopsies of 9.5% and 64%, respectively. Percentage of targeted biopsies remained relatively static, 7.9% and 8.2%. In 2013, 92% of non-targeted biopsies had no management change based on histology; in 2015 this was 90%. Of patients with alteration to management, only 0.4% and 0.7% were due to malignancy, in known high-risk patients. Reduction in non-targeted biopsies resulted in estimated annual savings in this trust of £36,000.

Conclusion

Development of local protocol reduces the numbers of non-targeted biopsies taken, without risk of harm from non-detection of malignant conditions, enabling a significant reduction in workload within busy histopathology services, with significant cost savings. Localised protocols are adaptable to local population demographics.

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2vHVqP2
via IFTTT